Skip to main content
PMC home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1985 Oct;76(4):1665–1672. doi: 10.1172/JCI112152

Metabolism of pantethine in cystinosis.

C T Wittwer, W A Gahl, J D Butler, M Zatz, J G Thoene
PMCID: PMC424158  PMID: 4056044

Abstract

D-Pantethine is a conjugate of the vitamin pantothenic acid and the low-molecular-weight aminothiol cysteamine. Pantethine is an experimental hypolipemic agent and has been suggested as a source of cysteamine in the treatment of nephropathic cystinosis. We treated four cystinotic children with 70-1,000 mg/kg per d oral D-pantethine and studied its metabolism. Pantethine was rapidly hydrolyzed to pantothenic acid and cysteamine; we could not detect pantethine in plasma after oral administration. The responsible enzyme, "pantetheinase," was highly active in homogenates of small intestinal mucosa and plasma. The Michaelis constant of the rat intestinal enzyme was 4.6 microM and its pH profile showed a broad plateau between 4 and 9. Pantothenate pharmacokinetics after orally administered pantethine followed an open two-compartment model with slow vitamin elimination (t1/2 = 28 h). Peak plasma pantothenate occurred at 2.5 h and levels over 250 microM were seen at 300 times normal. Apparent total body storage of pantothenate was significant (25 mg/kg), and plasma levels were elevated threefold for months after pantethine therapy. Plasma cysteamine concentrations after pantethine were similar to those reported after equivalent doses of cysteamine. However, at best only 80% white blood cell cystine depletion occurred. We conclude that pantethine is probably less effective than cysteamine in the treatment of nephropathic cystinosis and should only be considered in cases of cysteamine intolerance. Serum cholesterol was decreased an average of 14%, which supports the potential clinical significance of pantethine as a hypolipemic agent. Rapid in vivo hydrolysis of pantethine suggests that pantothenate or cysteamine may be the effectors of its hypolipemic action.

Full text

PDF
1666

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Avner E. D., Ellis D., Jaffe R. Veno-occlusive disease of the liver associated with cysteamine treatment of nephropathic cystinosis. J Pediatr. 1983 May;102(5):793–796. doi: 10.1016/s0022-3476(83)80261-3. [DOI] [PubMed] [Google Scholar]
  2. Branca D., Scutari G., Siliprandi N. Pantethine and pantothenate effect on the CoA content of rat liver. Int J Vitam Nutr Res. 1984;54(2-3):211–216. [PubMed] [Google Scholar]
  3. Butler J. D., Zatz M. Pantethine and cystamine deplete cystine from cystinotic fibroblasts via efflux of cysteamine-cysteine mixed disulfide. J Clin Invest. 1984 Aug;74(2):411–416. doi: 10.1172/JCI111436. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Butler J. D., Zatz M. Pantethine depletes cystinotic fibroblasts of cystine. J Pediatr. 1983 May;102(5):796–798. doi: 10.1016/s0022-3476(83)80262-5. [DOI] [PubMed] [Google Scholar]
  5. Corden B. J., Schulman J. D., Schneider J. A., Thoene J. G. Adverse reactions to oral cysteamine use in nephropathic cystinosis. Dev Pharmacol Ther. 1981;3(1):25–30. doi: 10.1159/000457418. [DOI] [PubMed] [Google Scholar]
  6. Duprè S., Cavallini D. Purification and properties of pantetheinase from horse kidney. Methods Enzymol. 1979;62:262–267. doi: 10.1016/0076-6879(79)62227-9. [DOI] [PubMed] [Google Scholar]
  7. Durr I. F., Cortas N. The reduction of pantethine by an extract of camel intestine. Biochem J. 1964 Jun;91(3):460–463. doi: 10.1042/bj0910460. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. FOX H. M., LINKSWILER H. Pantothenic acid excretion on three levels of intake. J Nutr. 1961 Dec;75:451–454. doi: 10.1093/jn/75.4.451. [DOI] [PubMed] [Google Scholar]
  9. GUEHRING R. R., HURLEY L. S., MORGAN A. F. Cholesterol metabolism in pantothenic acid deficiency. J Biol Chem. 1952 May;197(2):485–493. [PubMed] [Google Scholar]
  10. Gaddi A., Descovich G. C., Noseda G., Fragiacomo C., Colombo L., Craveri A., Montanari G., Sirtori C. R. Controlled evaluation of pantethine, a natural hypolipidemic compound, in patients with different forms of hyperlipoproteinemia. Atherosclerosis. 1984 Jan;50(1):73–83. doi: 10.1016/0021-9150(84)90009-1. [DOI] [PubMed] [Google Scholar]
  11. Gahl W. A., Schulman J. D., Thoene J. G., Schneider J. Hepatotoxicity of cysteamine? J Pediatr. 1983 Dec;103(6):1008–1009. doi: 10.1016/s0022-3476(83)80753-7. [DOI] [PubMed] [Google Scholar]
  12. Gahl W. A., Tietze F., Bashan N., Steinherz R., Schulman J. D. Defective cystine exodus from isolated lysosome-rich fractions of cystinotic leucocytes. J Biol Chem. 1982 Aug 25;257(16):9570–9575. [PubMed] [Google Scholar]
  13. HODGES R. E., OHLSON M. A., BEAN W. B. Pantothenic acid deficiency in man. J Clin Invest. 1958 Nov;37(11):1642–1657. doi: 10.1172/JCI103756. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Jonas A. J., Schneider J. A. A simple, rapid assay for cysteamine and other thiols. Anal Biochem. 1981 Jul 1;114(2):429–432. doi: 10.1016/0003-2697(81)90507-8. [DOI] [PubMed] [Google Scholar]
  15. Jonas A. J., Schneider J. A. Plasma cysteamine concentrations in children treated for cystinosis. J Pediatr. 1982 Feb;100(2):321–323. doi: 10.1016/s0022-3476(82)80665-3. [DOI] [PubMed] [Google Scholar]
  16. Jonas A. J., Smith M. L., Schneider J. A. ATP-dependent lysosomal cystine efflux is defective in cystinosis. J Biol Chem. 1982 Nov 25;257(22):13185–13188. [PubMed] [Google Scholar]
  17. KNOTT R. P., TSAO D. P., MCCUTCHEON R. S., CHELDELIN V. H., KING T. E. Toxicity of pantetheine. Proc Soc Exp Biol Med. 1957 Jun;95(2):340–341. doi: 10.3181/00379727-95-23212. [DOI] [PubMed] [Google Scholar]
  18. Karnitz L. M., Gross C. J., Henderson L. M. Transport and metabolism of pantothenic acid by rat kidney. Biochim Biophys Acta. 1984 Jan 25;769(2):486–492. doi: 10.1016/0005-2736(84)90334-1. [DOI] [PubMed] [Google Scholar]
  19. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  20. Lundquist P., Mårtensson J., Sörbo B., Ohman S. Turbidimetry of inorganic sulfate, ester sulfate, and total sulfur in urine. Clin Chem. 1980 Jul;26(8):1178–1181. [PubMed] [Google Scholar]
  21. Melander A. Influence of food on the bioavailability of drugs. Clin Pharmacokinet. 1978 Sep-Oct;3(5):337–351. doi: 10.2165/00003088-197803050-00001. [DOI] [PubMed] [Google Scholar]
  22. Millard W. J., Sagar S. M., Landis D. M., Martin J. B. Cysteamine: a potent and specific depletor of pituitary prolactin. Science. 1982 Jul 30;217(4558):452–454. doi: 10.1126/science.7089575. [DOI] [PubMed] [Google Scholar]
  23. Nakamura H., Tamura Z. Studies on the metabolites in urine and feces of rat after oral administration of radioactive pantethine. Chem Pharm Bull (Tokyo) 1972 Sep;20(9):2008–2016. doi: 10.1248/cpb.20.2008. [DOI] [PubMed] [Google Scholar]
  24. Ono S., Kameda K., Abiko Y. Metabolism of panthethine in the rat. J Nutr Sci Vitaminol (Tokyo) 1974;20(3):203–213. doi: 10.3177/jnsv.20.203. [DOI] [PubMed] [Google Scholar]
  25. Orloff S., Butler J. D., Towne D., Mukherjee A. B., Schulman J. D. Pantetheinase activity and cysteamine content in cystinotic and normal fibroblasts and leukocytes. Pediatr Res. 1981 Jul;15(7):1063–1067. doi: 10.1203/00006450-198107000-00018. [DOI] [PubMed] [Google Scholar]
  26. Oshima R. G., Willis R. C., Furlong C. E., Schneider J. A. Binding assays for amino acids. The utilization of a cystine binding protein from Escherichia coli for the determination of acid-soluble cystine in small physiological samples. J Biol Chem. 1974 Oct 10;249(19):6033–6039. [PubMed] [Google Scholar]
  27. Palkovits M., Brownstein M. J., Eiden L. E., Beinfeld M. C., Russell J., Arimura A., Szabo S. Selective depletion of somatostatin in rat brain by cysteamine. Brain Res. 1982 May 20;240(1):178–180. doi: 10.1016/0006-8993(82)90660-6. [DOI] [PubMed] [Google Scholar]
  28. Pellett O. L., Smith M. L., Thoene J. G., Schneider J. A., Jonas A. J. Renal cell culture using autopsy material from children with cystinosis. In Vitro. 1984 Jan;20(1):53–58. doi: 10.1007/BF02633332. [DOI] [PubMed] [Google Scholar]
  29. Reibel D. K., Wyse B. W., Berkich D. A., Neely J. R. Coenzyme A metabolism in pantothenic acid-deficient rats. J Nutr. 1982 Jun;112(6):1144–1150. doi: 10.1093/jn/112.6.1144. [DOI] [PubMed] [Google Scholar]
  30. SCHWARTZ E., BAGDON R. E. TOXICITY STUDIES OF SOME DERIVATIVES OF PANTOTHENIC ACID. Toxicol Appl Pharmacol. 1964 May;6:280–283. doi: 10.1016/0041-008x(64)90068-7. [DOI] [PubMed] [Google Scholar]
  31. SKOOG W. A., BECK W. S. Studies on the fibrinogen, dextran and phytohemagglutinin methods of isolating leukocytes. Blood. 1956 May;11(5):436–454. [PubMed] [Google Scholar]
  32. Shigeta Y., Shichiri M. Urinary excretion of pantothenic acid and pantethine in human subjects. J Vitaminol (Kyoto) 1966 Sep 10;12(3):186–191. doi: 10.5925/jnsv1954.12.186. [DOI] [PubMed] [Google Scholar]
  33. Thoene J. G., Lemons R. Cystine depletion of cystinotic tissues by phosphocysteamine (WR638). J Pediatr. 1980 Jun;96(6):1043–1044. doi: 10.1016/s0022-3476(80)80637-8. [DOI] [PubMed] [Google Scholar]
  34. Thoene J. G., Oshima R. G., Crawhall J. C., Olson D. L., Schneider J. A. Cystinosis. Intracellular cystine depletion by aminothiols in vitro and in vivo. J Clin Invest. 1976 Jul;58(1):180–189. doi: 10.1172/JCI108448. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. WIRTSCHAFTER Z. T., WALSH J. R. Hepatocellular lipid changes produced by pantothenic acid excess. Ann Surg. 1962 Jul;156:97–104. doi: 10.1097/00000658-196207000-00019. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Wittwer C. T., Burkhard D., Ririe K., Rasmussen R., Brown J., Wyse B. W., Hansen R. G. Purification and properties of a pantetheine-hydrolyzing enzyme from pig kidney. J Biol Chem. 1983 Aug 25;258(16):9733–9738. [PubMed] [Google Scholar]
  37. Wittwer C., Wyse B., Hansen R. G. Assay of the enzymatic hydrolysis of pantetheine. Anal Biochem. 1982 May 15;122(2):213–222. doi: 10.1016/0003-2697(82)90273-1. [DOI] [PubMed] [Google Scholar]
  38. Wyse B. W., Wittwer C., Hansen R. G. Radioimmunoassay for pantothenic acid in blood and other tissues. Clin Chem. 1979 Jan;25(1):108–110. [PubMed] [Google Scholar]
  39. Yoshimura H., Shiraki H., Oguri K., Tsukamoto H. [Metabolism of drugs. LXVI. Studies on the metabolic fate of pantethine]. Yakugaku Zasshi. 1970 Mar;90(3):364–369. doi: 10.1248/yakushi1947.90.3_364. [DOI] [PubMed] [Google Scholar]
  40. Yudkoff M., Foreman J. W., Segal S. Effects of cysteamine therapy in nephropathic cystinosis. N Engl J Med. 1981 Jan 15;304(3):141–145. doi: 10.1056/NEJM198101153040303. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES